|
|
![]() |
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 113, Issue 6 1089-1096, Copyright © 2000 by Company of Biologists
JOURNAL ARTICLES |
CS Downes, CZ Bachrati, SJ Devlin, M Tommasino, TJ Cutts, JV Watson, I Rasko and RT Johnson
Department of Biomedical Science, University of Ulster, Coleraine BT52 1SA, UK. cs.downes@ulst.ac.uk
In eukaryotic cells arrested in S-phase, checkpoint controls normally restrain mitosis until after replication. We have identified an array of previously unsuspected factors that modulate this restraint, using transformed hamster cells in which cycle controls are known to be altered in S-phase arrest. Arrested cells accumulate cyclin B, the regulatory partner of the mitotic p34(cdc2) kinase, which is normally not abundant until late G(2) phase; treatment of arrested cells with caffeine produces rapid S-phase condensation. We show here that such S-phase checkpoint slippage, as visualised through caffeine-dependent S-phase condensation, correlates with rodent origin and transformed status, is opposed by reverse transformation, and is favoured by c-src and opposed by wnt1 overexpression. Slippage is also dependent on a prolonged replicative arrest, and is favoured by arrest with hydroxyurea, which inhibits ribonucleotide reductase. This last is a key enzyme in deoxyribonucleotide synthesis, recently identified as a determinant of malignancy. Addition of deoxyribonucleosides shows that rapid S-phase condensation is suppressed by a novel checkpoint mechanism: purine (but not pyrimidine) deoxyribonucleosides, like reverse transformation, suppress cyclin B/p34(cdc2) activation by caffeine, but not cyclin B accumulation. Thus, ribonucleotide reductase has an unexpectedly complex role in mammalian cell cycle regulation: not only is it regulated in response to cycle progression, but its products can also reciprocally influence cell cycle control kinase activation.
This article has been cited by other articles:
![]() |
D. Wilsker and F. Bunz Loss of ataxia telangiectasia mutated- and Rad3-related function potentiates the effects of chemotherapeutic drugs on cancer cell survival Mol. Cancer Ther., April 1, 2007; 6(4): 1406 - 1413. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wang and Z. Liu Arabidopsis Ribonucleotide Reductases Are Critical for Cell Cycle Progression, DNA Damage Repair, and Plant Development PLANT CELL, February 1, 2006; 18(2): 350 - 365. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Yao, Z. Zhang, X. An, B. Bucci, D. L. Perlstein, J. Stubbe, and M. Huang Subcellular localization of yeast ribonucleotide reductase regulated by the DNA replication and damage checkpoint pathways PNAS, May 27, 2003; 100(11): 6628 - 6633. [Abstract] [Full Text] [PDF] |
||||